WallStSmart

Amazon.com Inc (AMZN)vsDanaher Corporation (DHR)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Amazon.com Inc generates 2898% more annual revenue ($742.78B vs $24.78B). DHR leads profitability with a 14.9% profit margin vs 12.2%. DHR appears more attractively valued with a PEG of 1.11. AMZN earns a higher WallStSmart Score of 65/100 (C+).

AMZN

Buy

65

out of 100

Grade: C+

Growth: 8.7Profit: 6.5Value: 3.3Quality: 6.0
Piotroski: 3/9Altman Z: 2.33

DHR

Buy

58

out of 100

Grade: C

Growth: 4.0Profit: 6.0Value: 4.0Quality: 6.3
Piotroski: 4/9Altman Z: 2.36
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

AMZNSignificantly Overvalued (-63.3%)

Margin of Safety

-63.3%

Fair Value

$166.05

Current Price

$272.68

$106.63 premium

UndervaluedFair: $166.05Overvalued
DHRSignificantly Overvalued (-28.4%)

Margin of Safety

-28.4%

Fair Value

$136.83

Current Price

$171.16

$34.33 premium

UndervaluedFair: $136.83Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AMZN4 strengths · Avg: 9.3/10
Market CapQuality
$2.92T10/10

Mega-cap, among the largest globally

EPS GrowthGrowth
74.8%10/10

Earnings expanding 74.8% YoY

Return on EquityProfitability
24.3%9/10

Every $100 of equity generates 24 in profit

Revenue GrowthGrowth
16.6%8/10

16.6% revenue growth

DHR4 strengths · Avg: 8.3/10
Market CapQuality
$124.33B9/10

Large-cap with strong market position

Price/BookValuation
2.3x8/10

Reasonable price relative to book value

Operating MarginProfitability
22.9%8/10

Strong operational efficiency at 22.9%

Free Cash FlowQuality
$1.08B8/10

Generating 1.1B in free cash flow

Areas to Watch

AMZN4 concerns · Avg: 3.3/10
PEG RatioValuation
1.904/10

Expensive relative to growth rate

P/E RatioValuation
32.5x4/10

Premium valuation, high expectations priced in

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Free Cash FlowQuality
$-18.17B2/10

Negative free cash flow — burning cash

DHR3 concerns · Avg: 3.7/10
P/E RatioValuation
34.0x4/10

Premium valuation, high expectations priced in

Revenue GrowthGrowth
3.7%4/10

3.7% revenue growth

Return on EquityProfitability
7.1%3/10

ROE of 7.1% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : AMZN

The strongest argument for AMZN centers on Market Cap, EPS Growth, Return on Equity. Revenue growth of 16.6% demonstrates continued momentum.

Bull Case : DHR

The strongest argument for DHR centers on Market Cap, Price/Book, Operating Margin. PEG of 1.11 suggests the stock is reasonably priced for its growth.

Bear Case : AMZN

The primary concerns for AMZN are PEG Ratio, P/E Ratio, Piotroski F-Score.

Bear Case : DHR

The primary concerns for DHR are P/E Ratio, Revenue Growth, Return on Equity.

Key Dynamics to Monitor

AMZN profiles as a growth stock while DHR is a value play — different risk/reward profiles.

AMZN carries more volatility with a beta of 1.47 — expect wider price swings.

AMZN is growing revenue faster at 16.6% — sustainability is the question.

DHR generates stronger free cash flow (1.1B), providing more financial flexibility.

Bottom Line

AMZN scores higher overall (65/100 vs 58/100) and 16.6% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Amazon.com Inc

CONSUMER CYCLICAL · INTERNET RETAIL · USA

Amazon.com, Inc. is an American multinational technology company which focuses on e-commerce, cloud computing, digital streaming, and artificial intelligence. It is one of the Big Five companies in the U.S. information technology industry, along with Google, Apple, Microsoft, and Facebook. The company has been referred to as one of the most influential economic and cultural forces in the world, as well as the world's most valuable brand.

Visit Website →

Danaher Corporation

HEALTHCARE · DIAGNOSTICS & RESEARCH · USA

Danaher Corporation is an American globally diversified conglomerate with its headquarters in Washington, D.C.. The company designs, manufactures, and markets professional, medical, industrial, and commercial products and services. The company's 3 platforms are Life Sciences, Diagnostics, and Environmental & Applied Solutions.

Want to dig deeper into these stocks?